Evidence‑Informed Guide to IV Infusions: Safety, Screening, and Sensible Expectations from Mold Manila

QUEZON CITY, Philippines — April 2026 — Mold Manila today published a practical, evidence‑informed primer to help the public make safe, informed decisions about intravenous (IV) infusions for wellness. While IV hydration and micronutrient drips can support fluid balance and help correct specific deficiencies confirmed by assessment, they are not cure‑alls and should only be administered following proper medical screening and by trained professionals in appropriate clinical settings.

What IV infusions can and cannot do: IV therapy delivers fluids and nutrients directly into the bloodstream, which may be useful for individuals who are dehydrated, have difficulty absorbing certain nutrients, or have documented deficiencies. However, evidence for routine “wellness” use in healthy individuals is limited. Most people can maintain hydration and nutrient status through diet and oral fluids. IV drips are not substitutes for balanced nutrition, sleep, exercise, or prescribed medical care.

Safety first—before, during, and after the drip: Mold Manila underscores comprehensive safety protocols, including pre‑infusion health screening (medical history, medications, allergies, pregnancy/breastfeeding status, and, where appropriate, labs), informed consent, use of sterile single‑use supplies, correct venous access, weight‑ and condition‑appropriate dosing and infusion rates, continuous monitoring of comfort and vital signs, and readiness to manage rare reactions. All procedures must be performed by licensed healthcare professionals in compliant clinical environments.

Individualized dosing matters: There is no one‑size‑fits‑all IV formula. Appropriate dosing depends on age, body weight, renal and hepatic function, coexisting conditions, and goals of care. Responsible practice avoids unnecessary “megadoses,” considers potential interactions (e.g., with chemotherapy, anticoagulants, or known allergies), and tailors frequency and composition to clinical need.

Who should avoid or delay IV drips: People with advanced kidney disease, heart failure, uncontrolled hypertension, a history of severe reactions to infusion components, active infection at the insertion site, or fluid/electrolyte disorders should not receive elective IV infusions without physician clearance. Pregnant or breastfeeding individuals, children, and those with conditions such as G6PD deficiency or ongoing chemotherapy require heightened caution and individualized medical advice.

Setting the right expectations: Short‑term effects may include improved hydration and, in those who are deficient, symptom relief. Not everyone will feel immediate changes, and benefits are typically temporary unless underlying factors are addressed. Potential side effects include bruising, vein irritation, headache, nausea, and, rarely, allergy, infection, or fluid overload. Any adverse symptoms should prompt clinical evaluation.

Mold Manila offers a range of IV options for eligible clients following screening, including The Mold Infusion, IV Micronutrient Drip, The Alabaster Drip, and The Ivory Push, with add‑ons such as 1200mg Glutathione, Collagen Platinum, Placenta Injection, and Zinc & Vitamin B Complex. Availability of specific formulations and add‑ons is subject to clinician assessment and applicable regulations; not all options are suitable for all clients.